Skip to main content

PharmacoEconomics - Open

Ausgabe 4/2023

Inhalt (13 Artikel)

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R

  • Open Access
  • Practical Application

Yi-Shu Lin, James F O’Mahony, Joost van Rosmalen

Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

  • Open Access
  • Review Article

Rebecca Bresnahan, Rachel Houten, Janette Greenhalgh, Sarah Nevitt, James Mahon, Sophie Beale, Angela Boland, Devarshi Bhattacharyya, Yenal Dundar, Joanne McEntee, Shreyans Gandhi, Nigel Fleeman, Marty Chaplin

Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania

  • Open Access
  • Original Research Article

Hiral Anil Shah, Tim Baker, Carl Otto Schell, August Kuwawenaruwa, Khamis Awadh, Karima Khalid, Angela Kairu, Vincent Were, Edwine Barasa, Peter Baker, Lorna Guinness

Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland

  • Open Access
  • Original Research Article

Esra Çakar, César Oniangue-Ndza, Ralph P. Schneider, Sven L. Klijn, Ursula M. Vogl, Christian Rothermundt, Jessica R. May

Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing

  • Open Access
  • Original Research Article

Fiona Koster, Marc R. Kok, Jaco van der Kooij, Geeke Waverijn, Angelique E. A. M. Weel-Koenders, Deirisa Lopes Barreto

Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective

  • Open Access
  • Original Research Article

Cesarius Singgih Wahono, Laniyati Hamijoyo, Yuriawati Hendrawan, Liyana Rakinaturia, Neha Mittal, Prabal Khanna, Minal Jain, Harry Isbagio

Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis

  • Open Access
  • Original Research Article

Julie Vanderpoel, Bruno Emond, Isabelle Ghelerter, Katherine Milbers, Marie-Hélène Lafeuille, Patrick Lefebvre, Lorie A. Ellis

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia

  • Open Access
  • Original Research Article

Eliza Kruger, Daniel Aggio, Hayley de Freitas, Andrew Lloyd

Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France

  • Open Access
  • Original Research Article

Megane Caillon, Benoit Brethon, Chrissy van Beurden-Tan, Romain Supiot, Antoine Le Mezo, Jean-Vannak Chauny, Istvan Majer, Arnaud Petit

Effect of Perioperative Oral Vitamin C Supplementation on In-Hospital Postoperative Medication Costs for Cardiac Surgery Patients: A Prospective, Single-Centre, Randomised Clinical Trial

  • Open Access
  • Original Research Article

Jan Heerman, Charlotte Boydens, Silvie Allaert, Koen Cathenis, Koen Deryckere, Henk Vanoverschelde

Systematic Review and Cost-Consequence Analysis of Ambu aScope 5 Broncho Compared with Reusable Flexible Bronchoscopes: Insights from Two US University Hospitals and an Academic Institution

  • Open Access
  • Original Research Article

Anders E. Kristensen, Jonathan S. Kurman, D. K. Hogarth, Sonali Sethi, Sabrina S. Sørensen